Myomo (NYSEAMERICAN:MYO) Shares Cross Below 50-Day Moving Average – What’s Next?

Shares of Myomo, Inc. (NYSEAMERICAN:MYO) crossed below its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of $1.38 and traded as low as $1.22. Myomo shares last traded at $1.27, with a volume of 498,523 shares traded.

Trending Headlines about Myomo

Investors following MYO have been watching these headlines:

• Positive Sentiment: The Zacks upgrade to Buy signals greater optimism about Myomo’s earnings outlook and may provide a near-term catalyst. Zacks article
• Positive Sentiment: HC Wainwright reduced its projected losses for FY2027–FY2028 and raised its estimates for FY2029 and FY2030, forecasting a shift to profitability in FY2029. The improved projections suggest the analyst sees a faster path toward earnings growth. MarketBeat analyst estimates
• Negative Sentiment: Despite the improved outlook, HC Wainwright still expects Myomo to post losses through FY2028, so the company remains dependent on executing its growth plans before reaching projected profitability.

Myomo Trading Down 3.2%

The company has a debt-to-equity ratio of 4.24, a quick ratio of 2.01 and a current ratio of 1.92. The company has a 50 day simple moving average of $1.37 and a two-hundred day simple moving average of $1.09.

Myomo (NYSEAMERICAN:MYO) last announced its quarterly earnings data on Monday, November 9th. The company reported ($0.07) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.01. Myomo had a negative return on equity of 183.47% and a negative net margin of 33.14%. The business had revenue of $12.33 million for the quarter, compared to analyst estimates of $11.51 million. On average, research analysts forecast that Myomo, Inc. will post -0.31 earnings per share for the current year.

Insiders Place Their Bets

In related news, insider Harry Kovelman sold 17,250 shares of the stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $1.73, for a total value of $29,842.50. Following the transaction, the insider owned 105,983 shares in the company, valued at approximately $183,350.59. This represents a 14.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In the last 90 days, insiders have sold 47,738 shares of company stock valued at $70,662. 12.14% of the stock is currently owned by corporate insiders.

Myomo Company Profile

Myomo, Inc. is a medical device company that develops and markets wearable robotic braces designed to help individuals with impaired upper-limb function regain movement and perform activities of daily living. Its principal product is the MyoPro, a lightweight, electrically powered orthosis that detects a user’s residual muscle signals and assists movement of the arm and hand. The MyoPro is intended for people affected by neuromuscular disorders and injuries, including stroke, brachial plexus injury, multiple sclerosis, traumatic brain injury and spinal cord injury.